When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CARA - Cara Therapeutics down 19% premarket on mixed results from Korsuva study
Cara Therapeutics Inc.
A Phase 2 clinical trial evaluating Cara Therapeutics' (NASDAQ:CARA) Korsuva (difelikefalin) (formerly CR845) for the treatment of pruritus (itchy skin) in patients with moderate-to-severe chronic kidney disease (CKD) met the primary endpoint.
More news on: Cara Therapeutics, Inc., Healthcare stocks news, Stocks on the move,